|
1. Determination of optimal MOI (multiplicity of infection), administration methods etc.
2. Detection of the infection efficiency of the AAV serotype against a specific cell type or tissue.
3. Using reporter genes to visualize the distribution and expression of AAV vectors in live animals, helping assess the biodistribution and persistence of gene delivery.
|